Minimum standards for clinical iPSCs: what the experts suggest

In this infographic, we summarize key clinical standards suggested by the experts involved in the GAiT global banking network, as described in their Regenerative Medicine White Paper.

Go to the profile of Regenerative Medicine
Mar 09, 2020
1
0

Despite the clinical potential of iPSCs being apparent since their discovery, the field has yet to form a consensus on what would be required for them to be utilized in the clinic successfully. 

In a White Paper published in Regenerative Medicine, experts from the GAiT global banking network outlined what they believed were the key tests to be undertaken before iPSCs were utilized as a treatment, as well as the minimum requirement from each test. 

Based on the standards described in this White Paper, we hope you enjoy this infographic summarizing the key tests and standards that the experts believe should be met when utilizing iPSCs in the clinic.   

Summary of iPSC White Paper
Leading iPSC experts in the GAiT global banking network have come together to discuss how the field should be approaching clinical grade iPSCs and the required tests. Here is a summary of the minimum dataset for clinical standards, as suggested by the experts in their Regenerative Medicine White Paper.

Loading...

Read the full paper in Regenerative Medicine now >>>

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.